Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
BICALUTAMIDE TABLETS. These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
Bicalutamide tablets 50 mg daily is indicatedfor use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2metastatic carcinoma of the prostate. Bicalutamide tablets 150 mg daily is not approvedfor use alone or with other treatments [see Clinical Studies (14.2)].
- generic_name
- bicalutamide
- product_names
- Bicalutamide
- ndc
- 51407-010, 51407-010-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en